Results 41 to 50 of about 68,171 (350)

Hepatitis C Education and Screening in a Rural Northern Vermont MAT Clinic [PDF]

, 2020
Increases in hepatitis C infection rates have mirrored increases in opioid use disorder. This project attempted to determine screening rates of HCV in a medication assisted treatment clinic for opioid use disorder.
Fitzsimons, Jack
core   +1 more source

The Experience of Intimate Partner Violence Among Pregnant Women Seeking Treatment for Opioid Use Disorder [PDF]

, 2020
Introduction: Intimate partner violence (IPV) is a major health issue among those with substance use disorder. A history of partner violence is associated with increased health problems and less improvement in treatment. The perinatal period is a time of
Abatemarco, PhD, MSW, Diane, Dewey, Julia   +1 more
core   +1 more source

Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial

Addiction Science & Clinical Practice, 2021
Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities.
Yih-Ing Hser, Allison J. Ober, Alex R. Dopp, Chunqing Lin, Katie P. Osterhage, Sarah E. Clingan, Larissa J. Mooney, Megan E. Curtis, Lisa A. Marsch, Bethany McLeman, Emily Hichborn, Laurie S. Lester, Laura-Mae Baldwin, Yanping Liu, Petra Jacobs, Andrew J. Saxon   +15 more
doaj   +1 more source

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Harm Reduction Journal, 2021
Background Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Anna Beth Parlier-Ahmad, Mishka Terplan, Dace S. Svikis, Laura Ellis, Caitlin E. Martin   +4 more
doaj   +1 more source

Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims [PDF]

, 2017
There is growing evidence that opioid prescribing in the United States follows a pattern in which patients who are at the highest risk of adverse outcomes from opioids are more likely to receive long-term opioid therapy.
Bair, Matthew J., Chang, Zheng, D’Onofrio, Brian M., Gibbons, Robert D., Hur, Kwan, Krebs, Erin E., Kroenke, Kurt, Quinn, Patrick D., Rickert, Martin E., Scott, Eric L.   +9 more
core   +1 more source

Buprenorphine added on brief cognitive behavioral therapy for treatment of methamphetamine use disorder [PDF]

, 2018
Background: Methamphetamine (MA) use remains a major public health concern around the world. Recent findings suggest that buprenorphine may be helpful for cocaine use reduction. Moreover, animal studies described reduced dopamine peak effect following MA
Dean AJ, Hassani-Abharian P, Hollister LE, Karimlou M, Kirchmayer U, Kosten TR, Mello NK, Nejati V, Raistrick D, Rothenberg JL,     +10 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial

BMC Public Health, 2021
Background A key strategy for mitigating the current opioid epidemic is expanded access to medications for treating opioid use disorder (MOUD). However, interventions developed to expand MOUD access have limited ability to engage opioid users at higher ...
Dennis P. Watson, James A. Swartz, Lisa Robison-Taylor, Mary Ellen Mackesy-Amiti, Kim Erwin, Nicole Gastala, Antonio D. Jimenez, Monte D. Staton, Sarah Messmer   +8 more
doaj   +1 more source

Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain [PDF]

, 2010
Background Opioid prescribing for chronic pain is common and controversial, but recommended clinical practices are followed inconsistently in many clinical settings.
AP Farmer, AX Garg, BM Kuehn, Brigit Vucic, Charles D Sintek, Dan Wang, David J Clark, Denise Daniels, DF Sittig, DL Hunt, DW Bates, G Worrall, J Gennari, Jack Rosenberg, Jan Elliott, JC Ballantyne, Jodie A Trafton, K Kawamoto, K Redmond, L Manchikanti, LM Frantsve, LM Yanni, M Glajchen, M Goldstein, Martha C Michel, Mary K Goldstein, MC Michel, Michael E Clark, MJ Pletcher, MK Goldstein, MK Goldstein, MK Goldstein, RA Miller, RN Shiffman, S Martins, Samson W Tu, SM Maviglia, SR Savage, Steve Balt, Susana B Martins, SW Tu, SW Tu, VA/DoD Opioid Therapy for Chronic Pain Working Group, W Dick, WM Tierney   +44 more
core   +3 more sources

COVID‐19: A new barrier to treatment for opioid use disorder in the emergency department

Journal of the American College of Emergency Physicians Open, 2021
Objective Start Treatment and Recover (STAR) is an emergency department (ED) program that expands access to medication for opioid use disorder by identifying patients with opioid use disorder and offering ED‐initiated buprenorphine/naloxone and rapid ...
Warren Grunvald, Ramsey Herrington, Roz King, Miles Lamberson, Scott Mackey, Sanchit Maruti, Richard Rawson, Daniel Wolfson   +7 more
doaj   +1 more source